your market intelligence analyst
Search Results
359 results
Your search is now limited to «Liver Cancer» expert search. 08/05/2020 08:29
Patients will be followed up to 60 months after transplant, to assess survival and HCC recurrence with biannual imagiology screening by triphasic CT scan.
More from
FeedNavigator (EU) 08/05/2020 07:48
No summary found
More from FeedNavigator (EU):
Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma [Corrigendum]
More from International Journal of COPD:
In the DEN-induced HCC model, YAP1 was strongly activated in tumors as demonstrated by nuclear localization of YAP1 protein and the gene signature we previously identified (SOH.
More from Molecular Cancer Research - Recent Issues (abstracts):
PubMed News (NIH) 08/04/2020
Overall design Paired tumor/non-tumor liver tissue samples from a cohort of 76 hepatocellular carcinoma patients undergoing surgery between 2015 and 2016 at the National Cancer Center of Mongolia were sequenced with RNA-Seq and Whole Exome Sequencing (WES.
More from PubMed News (NIH):
Meanwhile, the majority of patients with HCC have underlying chronic liver disease, and resection in this population is fraught with the potential for complications.
More from Clinical Cancer Research - Recent Issues (abstracts):
Cancer Cell International 08/02/2020 20:00
Table 1 Correlation between hsa_circ_0000517 expression and clinicopathological parameters of hepatocellular carcinoma patients (n = 50) Cell culture and transfection Hepatic epithelial cells THLE-2 and HCC cell lines (HCCLM3, Huh7, and MHCC97-H) were purchased from BeNa Culture Collection (Suzhou, China.
More from Cancer Cell International:
Business Wire 07/30/2020 09:50
Furthermore, the increasing prevalence of liver cancer is expected to propel growth of the global chronic liver diseases therapeutics market during the forecast period.
More from Business Wire: 07/30/2020 05:53
If left untreated, MAFLD can lead to serious complications like liver fibrosis (scarring), cirrhosis, liver failure and liver cancer, as well as cardiovascular and metabolic issues.
More from
Evidence from randomised trials on local ablative techniques for colorectal liver metastases is limited.
More from U.S. Department of Health & Human Services - (HHS):
HCC-LM3 cells were treated with cyclopamine (20 μM), GANT61 (20 μM) or vehicle (DMSO) for 48 h.
More from Cell Communication & Signaling:
GlobeNewswire 07/23/2020 16:01
Theratechnologies Reports That Tesamorelin Improves Liver Health Toronto Stock Exchange:TH.
More from GlobeNewswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications